show significant lower kidney, liver and spleen uptake of 18F-anti-MMR VHH compared to 99mTc-anti-MMR VHH in MMR-deficient tumor models and low bone uptake indicated that no in vivo defluorination occurred (21). Here, MRC1 is linked to neoplasm.